Skip to main content

International Journal of Clinical Oncology

Ausgabe 1/2014

Inhalt (34 Artikel)

Review Article

Ever-advancing chronic myeloid leukemia treatment

Shinya Kimura, Toshihiko Ando, Kensuke Kojima

Original Article

Predictive significance of mean apparent diffusion coefficient value for responsiveness of temozolomide-refractory malignant glioma to bevacizumab: preliminary report

Motoo Nagane, Keiichi Kobayashi, Masaki Tanaka, Kazuhiro Tsuchiya, Yukiko Shishido-Hara, Saki Shimizu, Yoshiaki Shiokawa

Original Article

Chronological shifts and changing causes of death after radiotherapy for early-stage oral cancer

Rina Fujisawa, Hitoshi Shibuya, Naoki Harata, Keiko Yuasa-Nakagawa, Kazuma Toda, Keiji Hayashi

Original Article

Neck dissection after chemoradiotherapy for oropharyngeal and hypopharyngeal cancer: the correlation between cervical lymph node metastasis and prognosis

Nobuhiro Hanai, Daisuke Kawakita, Taijiro Ozawa, Hitoshi Hirakawa, Takeshi Kodaira, Yasuhisa Hasegawa

Original Article

Is postoperative adjuvant chemoradiotherapy necessary for high-risk oropharyngeal squamous cell carcinoma?

Tomoya Yokota, Tetsuro Onitsuka, Kimihide Kusafuka, Hirofumi Ogawa, Yusuke Onozawa, Masahiro Nakagawa, Yoshiyuki Iida, Tomoyuki Kamijo, Tetsuo Nishimura, Takashi Nakajima, Narikazu Boku, Hirofumi Yasui

Original Article

Frequency of epidermal growth factor receptor mutations in Bangladeshi patients with adenocarcinoma of the lung

Shakibur Rahman, Nobuyuki Kondo, Kazue Yoneda, Teruhisa Takuwa, Masaki Hashimoto, Hayato Orui, Yoshitomo Okumura, Fumihiro Tanaka, Kanako Kumamoto, Mohammad Golam Mostafa, Golam Mohiuddin Akbar Chowdhury, Akramul Haque, Seiki Hasegawa

Original Article

Prognostic factors for patients in postoperative brain metastases from surgically resected non-small cell lung cancer

Jin Sakamoto, Makoto Sonobe, Masashi Kobayashi, Masashi Ishikawa, Ryutaro Kikuchi, Daisuke Nakajima, Tetsu Yamada, Ei Nakayama, Tsuyoshi Takahashi, Toshihiko Sato, Fengshi Chen, Toru Bando, Hiroshi Date

Original Article

A feasibility trial of postoperative adjuvant chemotherapy with S-1, an oral fluoropyrimidine, for elderly patients with non-small cell lung cancer: a report of the Lung Oncology Group in Kyushu (LOGIK) protocol 0901

Riichiroh Maruyama, Noriyuki Ebi, Junji Kishimoto, Masato Kato, Tokujiro Yano, Yoshinori Nagamatsu, Shuichi Tsukamoto, Shinji Akamine, Sho Saeki, Yukito Ichinose

Original Article

Comparison of chemotherapeutic efficacy between LCNEC diagnosed using large specimens and possible LCNEC diagnosed using small biopsy specimens

Takaaki Tokito, Hirotsugu Kenmotsu, Reiko Watanabe, Ichiro Ito, Takehito Shukuya, Akira Ono, Yukiko Nakamura, Asuka Tsuya, Tateaki Naito, Haruyasu Murakami, Toshiaki Takahashi, Yasuhisa Ohde, Haruhiko Kondo, Masahiro Endo, Toru Kameya, Takashi Nakajima, Keita Mori, Nobuyuki Yamamoto

Original Article

Changes of immunological parameters with administration of Japanese Kampo medicine (Juzen-Taihoto/TJ-48) in patients with advanced pancreatic cancer

Tetsuya Ikemoto, Mitsuo Shimada, Shuichi Iwahashi, Yu Saito, Mami Kanamoto, Hiroki Mori, Yuji Morine, Satoru Imura, Tohru Utsunomiya

Original Article

Inverse associations between serum concentrations of zeaxanthin and other carotenoids and colorectal neoplasm in Japanese

Yusuke Okuyama, Kotaro Ozasa, Keiichi Oki, Hoyoku Nishino, Sotaro Fujimoto, Yoshiyuki Watanabe

Original Article

DBC1 is over-expressed and associated with poor prognosis in colorectal cancer

Yongguo Zhang, Yong Gu, Sumei Sha, Xiangyun Kong, Hongwu Zhu, Bin Xu, Yijun Li, Kaichun Wu

Original Article

Degraded DNA may induce discordance of KRAS status between primary colorectal cancer and corresponding liver metastases

Yuka Kaneko, Hidekazu Kuramochi, Go Nakajima, Yuji Inoue, Masakazu Yamamoto

Original Article

Extremely poor postrecurrence oncological outcome for patients with recurrent mucinous ovarian cancer

Hiroaki Kajiyama, Mika Mizuno, Kiyosumi Shibata, Michiyasu Kawai, Tetsuro Nagasaka, Fumitaka Kikkawa

Original Article

Promoter methylation of DAPK1, FHIT, MGMT, and CDKN2A genes in cervical carcinoma

Chiaki Banzai, Koji Nishino, Jinhua Quan, Kosuke Yoshihara, Masayuki Sekine, Tetsuro Yahata, Kenichi Tanaka

Original Article

Clinical outcome of pelvic exenteration in patients with advanced or recurrent uterine cervical cancer

Sota Tanaka, Satoru Nagase, Michiko Kaiho-Sakuma, Tomoyuki Nagai, Hiroki Kurosawa, Masafumi Toyoshima, Hideki Tokunaga, Takeo Otsuki, Hiroki Utsunomiya, Tadao Takano, Hitoshi Niikura, Kiyoshi Ito, Nobuo Yaegashi

Original Article

Clinical variables for predicting metastatic renal cell carcinoma patients who might not benefit from cytoreductive nephrectomy: neutrophil-to-lymphocyte ratio and performance status

Yoshio Ohno, Jun Nakashima, Makoto Ohori, Ayako Tanaka, Takeshi Hashimoto, Tatsuo Gondo, Tadashi Hatano, Masaaki Tachibana

Original Article

Evaluation of long-term outcome for patients with renal cell carcinoma after surgery: analysis of cancer deaths occurring more than 10 years after initial treatment

Yuki Kyoda, Ko Kobayashi, Megumi Hirobe, Tetsuya Shindo, Fumimasa Fukuta, Kohei Hashimoto, Toshiaki Tanaka, Akiko Tonooka, Hiroshi Kitamura, Satoshi Takahashi, Naoya Masumori, Tadashi Hasegawa, Taiji Tsukamoto

Original Article

Clinical outcomes of urothelial carcinoma of the prostate detected in radical cystectomy specimens

Koji Ichihara, Naoya Masumori, Hiroshi Kitamura, Tadashi Hasegawa, Taiji Tsukamoto

Original Article

Clinical outcomes by relative docetaxel dose and dose intensity as chemotherapy for Japanese patients with castration-resistant prostate cancer: a retrospective multi-institutional collaborative study

Naoto Kamiya, Hiroyoshi Suzuki, Takeshi Ueda, Naohide Sato, Hiroomi Nakatsu, Kazuo Mikami, Nobuo Sato, Kazushi Nomura, Koichiro Akakura, Tatsuya Okano, Takemasa Ooki, Yukio Naya, Sho Ota, Motoyuki Masai, Tomohiko Ichikawa

Original Article

Weekly, low-dose docetaxel combined with estramustine for Japanese castration-resistant prostate cancer: its efficacy and safety profile compared with tri-weekly standard-dose treatment

Yasutomo Nakai, Kazuo Nishimura, Masashi Nakayama, Motohide Uemura, Hitoshi Takayama, Norio Nonomura, Akira Tsujimura

Original Article

Safe lumbar puncture under analgo-sedation in children with acute lymphoblastic leukemia

Palma Maurizi, Ida Russo, Daniela Rizzo, Antonio Chiaretti, Paola Coccia, Giorgio Attinà, Antonio Ruggiero, Riccardo Riccardi

Original Article

Analysis of chemotherapy-induced neutropenia and optimal timing for prophylactic use of G-CSF in B-cell non-Hodgkin lymphoma patients treated with R-CHOP

Hisaharu Shikata, Yoshihiro Yakushijin, Jun Yamanouchi, Taichi Azuma, Masaki Yasukawa

Original Article

Association of interleukin-10, tumor necrosis factor-α and transforming growth factor-β gene polymorphisms with the outcome of diffuse large B-cell lymphomas

Olivera Tarabar, Bojana Cikota-Aleksić, Ljiljana Tukić, Nenad Milanović, Aleksandar Aleksić, Zvonko Magić

Original Article

Dominant lymph drainage in the upper extremity and upper trunk region: evaluation of lymph drainage in patients with skin melanomas

Toshihiko Hayashi, Hiroshi Furukawa, Akihiko Oyama, Emi Funayama, Akira Saito, Yuhei Yamamoto

Original Article

Limitation of indocyanine green fluorescence in identifying sentinel lymph node prior to skin incision in cutaneous melanoma

Kenjiro Namikawa, Arata Tsutsumida, Ryota Tanaka, Junji Kato, Naoya Yamazaki

Letter to the Editor

Fibromyalgia and breast cancer

Ozgur Tanriverdi, Derya Kaskari

Letter to the Editor

Reply to a letter from Ozgur Tanriverdi and Derya Kaskari regarding “Frequency of fibromyalgia syndrome in breast cancer patients”

Nuray Akkaya, Nilgün Simsir Atalay, Selin Taflan Selcuk, Hakan Alkan, Necdet Catalbas, Füsun Sahin

Erratum

Erratum to: Risk-stratified survival rates and predictors of biochemical recurrence after radical prostatectomy in a Nara, Japan, cohort study

Nobumichi Tanaka, Kiyohide Fujimoto, Akihide Hirayama, Kazumasa Torimoto, Eijiro Okajima, Masahiro Tanaka, Makito Miyake, Keiji Shimada, Noboru Konishi, Yoshihiko Hirao

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.